Sector consensus ICON Public Limited Company

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 13/01/2026 GMT			5-day change	1st Jan Change
183.29 ^USD	+1.74%		-7.23%	+0.59%

01-08	Peace Was Cheaper
01-08	Truist Downgrades ICON PLC to Hold From Buy, Trims Price Target to $222 From $231	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
ICON PUBLIC LIMITED COMPANY	US$205.69	+14.18%	16
LONZA GROUP AG	CHF 678.09	+19.85%	22
IQVIA HOLDINGS INC.	US$257.5	+6.91%	20
BEONE MEDICINES AG	US$402.18	+20.42%	25
CELLTRION, INC.	₩235,751.77	+10.16%	22
REVOLUTION MEDICINES, INC.	US$88.94	-24.09%	18
MEDPACE HOLDINGS, INC.	US$542.33	-9.49%	12
EUROFINS SCIENTIFIC SE	€67.32	-6.11%	15
IONIS PHARMACEUTICALS, INC.	US$90.49	+10.81%	22
ASCENDIS PHARMA A/S	US$226.22	+26.55%	15
TEMPUS AI, INC.	US$87.92	+26.94%	12
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	US$204	-6.77%	15
BIO-TECHNE CORPORATION	US$70	+5.17%	12
QIAGEN N.V.	US$52.44	+10.99%	11
ABIVAX	€100.63	-3.24%	5
PRAXIS PRECISION MEDICINES, INC.	US$462.53	+67.74%	15
PHARMARON BEIJING CO., LTD.	CN¥37.01	+17.31%	12
HANGZHOU TIGERMED CONSULTING CO., LTD	CN¥65.86	+10.18%	13
Average	13,299.5	+10.97%	16
Weighted average by Cap.	23,155.4	+10.15%	18